Mitral regurgitation(MR)is one of the most common valvular heart diseases,imposing a significant economic burden on society.Transcatheter mitral valve replacement(TMVR),as an emerging therapeutic strategy for MR,is expected to fill the gap in the treatment of transcatheter edge-to-edge repair in the future.This article reviews the progress of TMVR clinical research both domestically and internationally in the past two years and analyzes the current challenges faced by TMVR research,such as mitral valve anatomy,device access transition,valve design,and mitral valve calcification.Finally,the prospects of mitral valve product research are discussed.
维普
万方数据